PTHS
Price
$34.68
Change
-$2.72 (-7.27%)
Updated
Nov 13 closing price
Capitalization
106.18M
Intraday BUY SELL Signals
SONN
Price
$5.40
Change
+$0.64 (+13.45%)
Updated
Nov 13 closing price
Capitalization
36.87M
Intraday BUY SELL Signals
Interact to see
Advertisement

PTHS vs SONN

Header iconPTHS vs SONN Comparison
Open Charts PTHS vs SONNBanner chart's image
Pelthos Therapeutics
Price$34.68
Change-$2.72 (-7.27%)
Volume$47.73K
Capitalization106.18M
Sonnet BioTherapeutics Holdings
Price$5.40
Change+$0.64 (+13.45%)
Volume$1.05M
Capitalization36.87M
PTHS vs SONN Comparison Chart in %
PTHS
Daily Signal:
Gain/Loss:
SONN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PTHS vs. SONN commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTHS is a Hold and SONN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (PTHS: $37.40 vs. SONN: $4.76)
Brand notoriety: PTHS and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTHS: 762% vs. SONN: 50%
Market capitalization -- PTHS: $106.18M vs. SONN: $36.87M
PTHS [@Biotechnology] is valued at $106.18M. SONN’s [@Biotechnology] market capitalization is $36.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTHS’s FA Score shows that 0 FA rating(s) are green whileSONN’s FA Score has 0 green FA rating(s).

  • PTHS’s FA Score: 0 green, 5 red.
  • SONN’s FA Score: 0 green, 5 red.
According to our system of comparison, both PTHS and SONN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTHS’s TA Score shows that 6 TA indicator(s) are bullish while SONN’s TA Score has 4 bullish TA indicator(s).

  • PTHS’s TA Score: 6 bullish, 4 bearish.
  • SONN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PTHS is a better buy in the short-term than SONN.

Price Growth

PTHS (@Biotechnology) experienced а +1.08% price change this week, while SONN (@Biotechnology) price change was +4.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTHS($106M) has a higher market cap than SONN($36.9M). PTHS YTD gains are higher at: 483.463 vs. SONN (226.027). PTHS has higher annual earnings (EBITDA): -8.54M vs. SONN (-13.97M). SONN has more cash in the bank: 321K vs. PTHS (59.2K). SONN has less debt than PTHS: SONN (68.8K) vs PTHS (2.31M). SONN has higher revenues than PTHS: SONN (1M) vs PTHS (0).
PTHSSONNPTHS / SONN
Capitalization106M36.9M287%
EBITDA-8.54M-13.97M61%
Gain YTD483.463226.027214%
P/E RatioN/A0.29-
Revenue01M-
Total Cash59.2K321K18%
Total Debt2.31M68.8K3,350%
FUNDAMENTALS RATINGS
SONN: Fundamental Ratings
SONN
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PTHSSONN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PTHS
Daily Signal:
Gain/Loss:
SONN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THS23.600.26
+1.11%
Treehouse Foods
ENB48.710.42
+0.87%
Enbridge
FDBC44.73-0.25
-0.56%
Fidelity D & D Bancorp
CVLT127.67-0.91
-0.71%
Commvault Systems
TENX6.99-0.05
-0.71%
Tenax Therapeutics

PTHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTHS has been closely correlated with SONN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTHS jumps, then SONN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTHS
1D Price
Change %
PTHS100%
+13.33%
SONN - PTHS
70%
Closely correlated
+3.48%
KLRS - PTHS
43%
Loosely correlated
-2.17%
LIXT - PTHS
34%
Loosely correlated
+7.71%
MBIO - PTHS
29%
Poorly correlated
+0.81%
PASG - PTHS
27%
Poorly correlated
+21.82%
More

SONN and

Correlation & Price change

A.I.dvisor tells us that SONN and PRME have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SONN and PRME's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
+3.48%
PRME - SONN
29%
Poorly correlated
-9.44%
NTRB - SONN
28%
Poorly correlated
-3.78%
DWTX - SONN
27%
Poorly correlated
+3.37%
JSPR - SONN
26%
Poorly correlated
+4.12%
PHAR - SONN
25%
Poorly correlated
+8.61%
More